Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
contribute to disease severity of coronavirus disease 2019 (COVID-19). …

Background Autoimmune polyendocrine syndrome type 1 (APS-1) is a life-threatening,
autosomal recessive syndrome caused by autoimmune regulator (AIRE) deficiency. In APS-1, self…

Pathogenic autoreactive antibodies that may be associated with life-threatening coronavirus
disease 2019 (COVID-19) remain to be identified. Here, we show that self-assembled …

Mutations in genes coding for proteasome subunits and/or proteasome assembly helpers
typically cause recurring autoinflammation referred to as chronic atypical neutrophilic …

Neutrophilic inflammation is a hallmark of many monogenic autoinflammatory diseases;
pathomechanisms that regulate extravasation of damaging immune cells into surrounding …

Pediatric COVID-19 (pCOVID-19) is rarely severe, however a minority of SARS-CoV-2-infected
children may develop MIS-C, a multisystem inflammatory syndrome with significant …

Understanding early innate immune responses to coronavirus disease 2019 (COVID-19) is
crucial to developing targeted therapies to mitigate disease severity. Severe acute …

The human genome encodes for over 1,500 RNA-binding proteins (RBPs), which coordinate
regulatory events on RNA transcripts. Most studies of RBPs have concentrated on their …

SARS-CoV-2 infection is responsible for more than 800,000 deaths in the USA (https://coron
avirus. jhu. edu/data/morta lity). Patients with autoinflammatory diseases caused by innate …

Objectives Patients with chronic atypical neutrophilic dermatosis with lipodystrophy and
elevated temperature/proteasome-associated autoinflammatory syndrome (CANDLE/PRAAS) …